Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
SRPT Sarepta Therapeutics Inc
AAC AAC Holdings Inc
PWR Quanta Services Inc
GE General Electric Co
NKE Nike Inc
NFLX Netflix Inc
UNP Union Pacific Corp
AMTD TD Ameritrade Holding Corp
INO Inovio Pharmaceuticals Inc
Go

Health Care : Biotechnology | Large Cap GrowthCompany profile

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

Price
Delayed
$376.62
Day's Change
-4.56 (-1.20%)
Bid
--
Ask
--
B/A Size
--
Day's High
386.35
Day's Low
370.60
Volume
(Average)

Today's volume of 613,583 shares is on pace to be in-line with REGN's 10-day average volume of 819,516 shares.

613,583
  • Prev Close
    381.17
  • Today's Open
    381.70
  • Day's Range
    370.60-386.35
  • Avg Vol (10-day)
    819.5K
  • Last (time)
    3:10p ET 12/17/18
  • Last (size)
    100
  • 52-Wk Range
    281.89 - 416.49
    LowHigh
  • (05/09/18 - 08/30/18)
    9.57%
  • 31.2%
  • Market Cap
    40.0B
  • Shares Outstanding
    106.3M
  • 18.46
  • 20.65x
  • No dividend
  • Ex-dividend
    No dividend
  • 1.2
  • 71.58
  • (% of float 11/30/18)
    2.69

Latest News

December 03, 2018
4:40 pm ET
MarketWatch
8:00 am ET
Globe Newswire
December 01, 2018
12:00 pm ET
PR Newswire
November 20, 2018
5:00 pm ET
PR Newswire
November 11, 2018
8:15 am ET
PR Newswire
8:14 am ET
PR Newswire
November 10, 2018
9:54 am ET
MarketWatch
November 07, 2018
5:01 pm ET
PR Newswire
5:00 pm ET
PR Newswire
November 06, 2018
8:35 am ET
MarketWatch
8:00 am ET
PR Newswire
6:30 am ET
PR Newswire
12:59 am ET
PR Newswire
October 29, 2018
7:43 am ET
MarketWatch
October 28, 2018
7:32 am ET
MarketWatch
October 26, 2018
7:00 am ET
PR Newswire
October 25, 2018
9:19 am ET
MarketWatch
7:00 am ET
PR Newswire
October 24, 2018
9:20 am ET
Globe Newswire
October 22, 2018
7:00 am ET
PR Newswire
October 19, 2018
5:55 pm ET
PR Newswire
5:55 pm ET
PR Newswire
7:00 am ET
PR Newswire
October 16, 2018
8:00 am ET
PR Newswire
12:59 am ET
PR Newswire
October 08, 2018
6:05 pm ET
PR Newswire
9:30 am ET
PR Newswire
September 28, 2018
4:51 pm ET
MarketWatch
4:40 pm ET
PR Newswire
4:39 pm ET
PR Newswire
August 07, 2018
7:54 am ET
MarketWatch
August 06, 2018
9:39 am ET
MarketWatch
June 27, 2018
8:56 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.